Matinas BioPharma Holdings, Inc.
Symbol: MTNB (NYSE)
1.71
▲ (5.56%) 0.090
Company Description:
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.
Key Stats
- Today's Open: $1.653
- Today's High: $1.71
- Today's Low: $1.64
- Today's Volume: 6.95K
- Yesterday Close: $1.62
- Yesterday High: $1.7
- Yesterday Low: $1.59
- Yesterday Volume: 27.37K
- Last Min Volume: 15
- Last Min High: $1.71
- Last Min Low: $1.71
- Last Min VWAP: $1.71
Company Profile
- Name: Matinas BioPharma Holdings, Inc.
- Website: https://www.matinasbiopharma.com
- Listed Date: 2014-07-21
- Location: BEDMINSTER, NJ
- Market Status: Active
- CIK Number: 0001582554
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $9.00M
- Round Lot: 100
- Outstanding Shares: 5.55M
- Asset Type: CS
RECENT FILINGS FOR MTNB
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-19 | SCHEDULE 13G | View |
| 2025-08-18 | 8-K | View |
| 2025-08-14 | 10-Q | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-06 | 8-K | View |
| 2025-06-23 | S-8 | View |
| 2025-06-23 | 8-K | View |
| 2025-05-15 | 10-Q | View |
| 2025-05-12 | DEF 14A | View |
| 2025-05-02 | PRE 14A | View |
| 2025-05-02 | 4 | View |
| 2025-05-02 | 4 | View |
| 2025-05-02 | 4 | View |
| 2025-05-02 | 4 | View |
| 2025-05-02 | 4 | View |
| 2025-05-02 | 8-K | View |
| 2025-04-29 | EFFECT | View |
| 2025-04-29 | ARS | View |
| 2025-04-29 | 424B3 | View |
| 2025-04-28 | CORRESP | View |
Latest News on MTNB